Centenara Labs
Company
Centenara Labs develops 2 assets, the furthest preclinical (Centenara Labs Telomere Program). Mostly small molecule.
- 2
- Assets
- Furthest stage
- Preclinical
- Raised
- US$75m
- 0
- Trials
- 0
- Signals
Pipeline
2Centenara Labs Telomere Program
Restores telomere function in age-related disorders.
Preclinical
Centenara Labs Vascular Program
Slows down and reverses damage to brain vasculature.
Preclinical, Small molecule
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Funding rounds and grants1
- People16